Variant · Snv
HLA-DRB1 NM_002124.4(HLA-DRB1):c.176A>T (p.Tyr59Phe)
CI-VAR-00417232Explore in graph →p.Tyr59PheNM_002124.4:c.176A>TClinVar 4326266
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 4326266 | Likely benign | criteria provided, single submitter | 1 | Thyroid cancer, nonmedullary, 1; Ovarian cancer; Lymphoma; Nonpapillary renal cell carcinoma; Chronic lymphocytic leukemia/small lymphocytic lymphoma | germline | 2 | Nov 27, 2024 | clinvar |